See today's BioWorld Science
To read the full story, subscribe or sign in.
Endocrine/metabolic

BI-9787 made available for metabolic disorder studies

July 30, 2024
Scientists at Boehringer Ingelheim GmbH have made the ketohexokinase (KHK) inhibitor BI-9787 freely available as a tool compound via the company’s Opnme program.
BioWorld Science License Endocrine/metabolic Small molecule